Safely Disposing of Surplus Prescription Opioids
NCT03855241 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 499
Last updated 2019-09-23
Summary
This study evaluates two interventions intended to increase the safe disposal of leftover prescription opioids, compared to no intervention. Participants will receive an informational sheet describing how to safely dispose of leftover prescription opioids, an informational sheet with a drug disposal kit, or no intervention. Participants will be randomized by day for pragmatic reasons.
Conditions
- Opioid Use
Interventions
- BEHAVIORAL
-
Informational Sheet
The informational sheet details how use opioid medicines safely, and lists ways to properly dispose of leftover opioids
- BEHAVIORAL
-
DisposeRx Drug Disposal kit
DisposeRx is a powder that is activated with water and traps leftover drugs (i.e. pills, capsules, caplets, liquids or tablets) in a semi-solid gel. The trapped drug cannot be retrieved from the resulting gel material for misuse, abuse or to leach into landfills. The participant can then throw away the biodegradable solid material in the prescription bottle into the trash, as it is safe for the environment.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Mark Bicket, MD · Johns Hopkins University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-06-05
- Primary Completion
- 2019-08-14
- Completion
- 2019-08-14
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of a Computerized Opioid Overdose Prevention Program
NCT02040077 ·Status: COMPLETED ·Phase: NA
-
Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD
NCT04316559 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults
NCT01046539 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder
NCT06538558 ·Status: RECRUITING ·Phase: PHASE1
-
Stimulant Overdose in the Medicaid Population: Who is at Risk, and When Are They at Risk
NCT05976984 ·Status: COMPLETED
-
Lofexidine for Inpatient Opiate Detox
NCT00235729 ·Status: COMPLETED ·Phase: PHASE3
-
Safe Return and Disposal of Unused Opioids
NCT03352479 ·Status: WITHDRAWN ·Phase: NA
-
Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment
NCT07024498 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain.
NCT00315445 ·Status: COMPLETED ·Phase: PHASE3
-
Aprepitant Effects on Oxycodone Response
NCT00999544 ·Status: COMPLETED ·Phase: NA
-
Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment Centers
NCT02871232 ·Status: UNKNOWN
-
Low-dose Buprenorphine Initiation for Opioid Use Disorder
NCT05450718 ·Status: RECRUITING ·Phase: PHASE4
-
Ketones for Opioid Craving
NCT07128524 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
NCT06651177 ·Status: RECRUITING ·Phase: PHASE2
-
Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder
NCT02044094 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid Withdrawal
NCT01863186 ·Status: COMPLETED ·Phase: PHASE3
-
Buprenorphine Combination Tablet Feasibility - 1
NCT00000298 ·Status: COMPLETED ·Phase: PHASE2
-
Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder
NCT05053503 ·Status: COMPLETED ·Phase: NA
-
The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain.
NCT00315874 ·Status: COMPLETED ·Phase: PHASE3
-
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence
NCT01549652 ·Status: COMPLETED ·Phase: NA
-
Safe Opioid Prescription Practice for Patients Discharged From Trauma Services
NCT02584881 ·Status: UNKNOWN ·Phase: NA
-
Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery.
NCT00315835 ·Status: COMPLETED ·Phase: PHASE2
-
Mobile & Online-Based Interventions to Lessen Pain
NCT05152134 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain
NCT01971632 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
NCT05011266 ·Status: RECRUITING ·Phase: PHASE2/PHASE3